Flow cytometric investigation of immune-response-related surface molecules on human colorectal cancers

International Journal of Cancer

Volumn 79, Issue 3, 1998, Pages 283-287

  Diederichsen, Axel C P ^a   Ostenhom, Anna C ^b   Kronborg, Ole ^a   Fenger, Claus ^a   Jensenius, Jens Christian ^c   Zeuthen, Jesper ^b   Christensen, Per B ^a   Kristensen, Tom ^a  

^a ODENSE UNIVERSITY HOSPITAL   (Denmark)

^b DANISH CANCER SOCIETY RESEARCH CENTER   (Denmark)

^c AARHUS UNIVERSITY   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

B7 ANTIGEN; CELL SURFACE MARKER; INTERCELLULAR ADHESION MOLECULE 1; LYMPHOCYTE FUNCTION ASSOCIATED ANTIGEN 3;

ADULT; AGED; ANTIGEN EXPRESSION; ARTICLE; CANCER STAGING; CLINICAL TRIAL; COLORECTAL CANCER; CONTROLLED STUDY; FEMALE; FLOW CYTOMETRY; HUMAN; IMMUNE RESPONSE; LYMPHOCYTIC INFILTRATION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROTEIN EXPRESSION; TUMOR IMMUNITY;

ADULT; AGED; ANTIGENS, CD58; ANTIGENS, CD80; ANTIGENS, NEOPLASM; COLORECTAL NEOPLASMS; FEMALE; FLOW CYTOMETRY; HISTOCOMPATIBILITY ANTIGENS CLASS I; HISTOCOMPATIBILITY ANTIGENS CLASS II; HUMANS; INTERCELLULAR ADHESION MOLECULE-1; LYMPHATIC METASTASIS; MALE; MIDDLE AGED;

EID: 0031777450     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0215(19980619)79:3<283::AID-IJC13>3.0.CO;2-9     Document Type: Article

References (22)

1. ALLISON, J.P. and KRUMMEL, M.F., The Yin and Yang of T cell costimulation. Science, 270, 932-933 (1995).
2. ANDERSEN, S.N., ROGNUM, T.O., LUND, E., MELING, G.I. and HAUGE, S., Strong HLA-DR expression in large bowel carcinomas is associated with good prognosis. Brit. J. Cancer, 68, 80-85 (1993).
3. BLOOM, S., SIMMONS, D. and JEWELL, D.P., Adhesion molecules intercellular adhesion molecule-1 (ICAM-1). ICAM-3 and B7 are not expressed by epithelium in normal or inflamed colon. Clin. exp. Immunol., 101, 157-163 (1995).
4. BOOMER, W.F., BROWNING, M.J., KRAUSA, P., ROWAN, A., BICKNELL, D.C. and BODMER, J.G., Tumor escape from immune response by variation in HLA expression and other mechanisms. Ann. N.Y. Acad. Sci., 690, 42-49 (1993).
5. BOON, T. and VAN DER BRUGGEN, P., Human tumor antigens recognized by T lymphocytes. J. exp. Med., 183, 725-729 (1996).
6. CHAUX, P., MOUTET, M., FAIVRE, J., MARTIN, F. and MARTIN, M., Inflammatory cells infiltrating human colorectal carcinomas express HLA class II but not B7-1 and B7-2 co-stimulatory molecules of the T-cell activation. Lab. Invest., 74, 975-983 (1996).
7. CHEN, L., ASHE, S., BRADY, W.A., HELLSTROM, I., HELLSTROM, K.E., LEDBETTER, J.A., MCGOWAN, P. and LINSLEY, P.S., Co-stimulation of antitumor immunity by the B7 counter-receptor for the T lymphocyte molecules CD28 and CTLA-4. Cell, 71, 1093-1102 (1992).
8. COVENTRY, B.J., NEOH, S.H., MANTZIORIS, B.X., SKINNER, J.M., ZOLA, H. and BRADLEY, J., A comparison of the sensitivity of immunoperoxidase staining methods with high-sensitivity fluorescence flow cytometry-antibody quantitation on the cell surface. J. Histochem. Cytochem., 42, 1143-1147 (1994).
9. DEANS, G.T., HEATLEY, M., ANDERSON, N., PATTERSON, C.C., ROWLANDS, B.J., PARKS, T.G. and SPENCE, R.A., Jass' classification revisited. J. Amer. Coll. Surg., 179, 11-17 (1994).
10. DENFELD, R.W., DIETRICH, A., WUTTIG, C., TANCZOS, E., WEISS, J.M., VANSCHEIDT, W., SCHOPF, E. and SIMON, J.C., In situ expression of B7 and CD28 receptor families in human malignant melanoma: relevance for T-cell-mediated anti-tumor immunity. Int. J. Cancer, 62, 259-265 (1995).
11. DIEDERICHSEN, A.C.P., HANSEN, T.P., NIELSEN, O., FENGER, C., JENSENIUS, J.C., CHRISTENSEN, P.B., KRISTENSEN, T. and ZEUTHEN, J., A comparison of flow cytometry with immunohistochemistry in human colorectal cancers. Acta pathol. microbiol. immunol. Scand., (1997) in press.
12. GARRIDO, F., CABRERA, T., LOPEZ NEVOT, M.A. and RIUZ CABELLO, F., HLA class I antigens in human tumors. Adv. Cancer Res., 67, 155-195 (1995).
13. JASS, J.R., LOVE, S.B. and NORTHOVER, J.M., A new prognostic classification of rectal cancer. Lancet, i, 1303-1306 (1987).
14. KAKLAMANIS, L., GATTER, K.C., HILL, A.B., MORTENSEN, N., HARRIS, A.L., KRAUSA, P., MCMICHAEL, A., BOOMER, J.G. and BODMER, W.F., Loss of HLA class-I alleles, heavy chains and beta 2-microglobulin in colorectal cancer. Int. J. Cancer. 51, 379-385 (1992).
15. LAZARIS, A.C., THEODOROPOULOS, G.E., DAVARIS, P.S., PANOUSSOPOULOS, D., NAKOPOULOU, L., KITTAS, C. and GOLEMATIS, B.C., Heat shock protein 70 and HLA-DR molecules tissue expression. Prognostic implications in colorectal cancer. Dis. Colon Rectum, 38, 739-745 (1995).
16. LEACH, D.R., KRUMMEL, M.F. and ALLISON, J.P., Enhancement of antitumor immunity by CTLA-4 blockade. Science, 271, 1734-1736 (1996).
17. LENGAUER, C., KINZLER, W.K. and VOGELSTEIN, B., Genetic instability in colorectal cancers. Nature (Lond.), 386, 623-627 (1997).
18. MOLLER, P., MOMBURG, F., KORETZ, K., MOLDENHAUER, G., HERFARTH, C., OTTO, H.F., HAMMERLING, G.J. and SCHLAG, P., Influence of major histocompatibility complex class I and II antigens on survival in colorectal carcinoma. Cancer Res. 51, 729-736 (1991).
19. MOORE, M., GHOSH, A.K. and JONES, D.J., MHC status of primary human colorectal carcinoma: biological significance and implications for host immune recognition. Acta chir. Scand. (Suppl.), 549, 17-25 (1989).
20. RANSOM, J.H., PELLE, B. and HANNA, M.G., JR., Expression of class II major histocompatibility complex molecules correlates with human colon tumor vaccine efficacy. Cancer Res. 52, 3460-3466 (1992).
21. SCHWARTZ, R.H., A cell culture model for T lymphocyte clonal anergy. Science, 248, 1349-1356 (1990).
22. TURNBULL, R.B., KYLE, K., WATSON, F.R. and SPRATT, T., Cancer of the colon: the influence of the no-touch isolation technic on survival rates. Ann. Surg., 166, 420-427 (1967).